This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Finance & Accounting for Bioscience Companies
September 18-19, 2024
Omni Boston Hotel at the SeaportBoston, MA

Rohit Anand
Executive Director of Finance & Controller at Tectonic Therapeutic


Corporate Controller with experience in biotech, asset management, the tech industries in accounting leadership. Adept with compliance, systems implementations, internal controls, complex accounting, critical thinking, IPO planning and execution, and SEC financial reporting. Accomplished at providing guidance and decision support to audit committees, executive teams, and building Accounting and Finance teams.

Leadership: Lead all financial activities related to Tectonic’s accounting, integrated its technical accounting and operations in accordance with GAAP and audit standards.

Business Performance Management: Ensured compliance with all US GAAP accounting and reporting requirements, including the preparation and filing of S-1 filing ultimately resulted in the IPO of Sigilon Therapeutics, Inc of $145 Million.

Strategic Thinking: Provide financial leadership for hyper-growth organizations which includes adoption of new accounting standards, design and implementation of ERP, HRIS, and procurement system with appropriate control environments and ensuring the resources available for the company are sufficient to meet its growth objectives.

Agenda Sessions

  • Best Practices for Finance Procedures